Natalie Marie Loera, OTR/L | |
1000 S Fremont Ave Unit 27, Alhambra, CA 91803-8849 | |
(213) 607-4400 | |
Not Available |
Full Name | Natalie Marie Loera |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1000 S Fremont Ave Unit 27, Alhambra, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215481676 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 18849 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Natalie Marie Loera, OTR/L 1000 S Fremont Ave Unit 27, Alhambra, CA 91803-8849 Ph: (213) 607-4400 | Natalie Marie Loera, OTR/L 1000 S Fremont Ave Unit 27, Alhambra, CA 91803-8849 Ph: (213) 607-4400 |
News Archive
A performance evaluation process used widely by Fortune 500 companies accurately and effectively assesses surgeons' adherence to core standards of excellence and spurs changes in behavior to improve surgical practice and teamwork, according to a new study published online as an "article in press" in the Journal of the American College of Surgeons.
The essence of postmodernism theme is that of an epochal shift, discontinuity, or rupture with modernity, bringing new social conditions and sociological principles with it (Baudrillard, 1988). Postmodernism views that the authority and status of the medical professionals does not exist anymore in the area of health care consistent with the postmodern message about the deconstruction of traditional centers of postindustrial authority (Cockerham et.al, 1997).
Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.
Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
Heading into a lame-duck session, "Congress has several other items left on its docket. … there's a rewrite of the 1099 tax reporting requirements under the health care bill, which presently require businesses to report every expense over $600.
› Verified 3 days ago
Guadalupe Yessenia Rodriguez, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 27, Alhambra, CA 91803 Phone: 562-333-3700 | |
Mei Shan Anita Chie, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 58 S 5th St Apt G, Alhambra, CA 91801 Phone: 469-569-2998 | |
Alexis Whitman, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 315 W Grand Ave, Apt B, Alhambra, CA 91801 Phone: 805-559-2181 | |
Jilianne Lauren Normandy, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Bldg A10n, Alhambra, CA 91803 Phone: 626-289-7472 | |
Shangmiaw Lin Sheu, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1118 S Garfield Ave, Suite #203, Alhambra, CA 91801 Phone: 626-284-6888 Fax: 626-289-5686 | |
Louisie Buzi, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 S Fremont Ave Unit 27, Alhambra, CA 91803 Phone: 626-289-7472 |